Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

AGA linked to worse COVID-19 outcomes in men.

PDI helps restore over-bleached hair's strength and structure by attaching special peptides.

Activin activation in skin cells speeds up wound healing without affecting scar quality.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.